- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Page 171
Sense Photonics grasps $26m series A
Lidar technology developer Sense Photonics has emerged from stealth with $26m in series A funding from investors co-led by the UC-backed Congruent Ventures.
Jun 12, 2019Cloudwise collects $25m in series D round
The Susquehanna International Group-backed app performance management software provider received $25m in a round that took its overall funding past $80m.
Jun 11, 2019Spacemaker constructs $25m series A round
NREP, Obos and the AF Gruppen-backed Construct Venture took part in a round that will support the AI-based design and construction simulation platform's international expansion.
Jun 11, 2019GuardKnox drives off with $21m series A
Faurecia, SAIC, Kardan, Allied Group and Cyphertech all took part in the round, which increased connected car security platform GuardKnox's overall funding to $24m.
Jun 10, 2019Step moves forward with series A
Teenager-focused digital banking app Step collected $22.5m in the Stripe-led series A round, which featured WndrCo and existing backer Sesame Ventures.
Jun 10, 2019WorkSpan locates $27m in series B round
The cloud-based collaboration network increased its overall funding to $36m with a series B round backed by Microsoft's M12 subsidiary.
Jun 6, 2019Carbon Lighthouse attracts Cox to lead round
Johnson Controls-backed energy efficiency services provider Carbon Lighthouse has received $32.6m in a round that included $20m from Cox Enterprises.
Jun 6, 2019OncoMyx sticks $25m series A
Boehringer Ingelheim Venture Fund co-led the oncology drug developer's series A round with Delos Capital and Xeraya Capital.
Jun 6, 2019OncoMyx hits $25m
OncoMyx Therapeutics was co-founded by ASU's Grant McFadden and will use the series A funding to advance the development of its lead asset aimed at several indications of cancer.
Jun 6, 2019Lung Therapeutics clears $36m series C
UT Health's pulmonary drug treatment spinout Lung Therapeutics has raised a $36m series C, adding to at least $55m in previous funding from backers including UT Horizon Fund.
Jun 5, 2019About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


